M2Q2: mHealth Messaging to Motivate Quitline Use Quitting

Sponsor
University of Massachusetts, Worcester (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03567993
Collaborator
Institute of Population, Health and Development, Vietnam (Other), National Institutes of Health (NIH) (NIH), Fogarty International Center of the National Institute of Health (NIH)
750
1
2
40.2
18.7

Study Details

Study Description

Brief Summary

The mHealth Messaging to Motivate Quitline Use and Quitting, or "M2Q2" study, is a collaborative research project for a mobile health intervention designed to motivate smoking cessation and encourage access to counseling. The study is for men and women smokers in Vietnam's Red River Delta region who are 18 years of age or older.

The primary hypothesis is that smokers in the M2Q2 intervention will have higher rates of smoking cessation, compared with the comparison group.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Comparison
  • Behavioral: Intervention
N/A

Detailed Description

The specific aims of the M2Q2 study are:

Aim 1: In collaboration with the Institute of Population, Health, and Development (PHAD) in

Vietnam, adapt a current, effective messaging system to Vietnam. The messaging system will:
  1. Motivate smokers to quit smoking, using tailored messages adapted to be culturally relevant.

  2. Encourage smokers to accept counseling services from the Quitline, and take advantage of nicotine replacement therapy (NRT) that will be provided by the Quitline to those willing to quit.

Aim 2: To engage with the Quitline, providing additional training in tobacco cessation counseling for those ready to quit, and motivational interventions for those not yet ready to quit.

Aim 3: To evaluate the impact of the messaging system on: access to the Quitline, use of nicotine replacement therapy, increase in self-efficacy, and six-month biochemically verified smoking cessation.

The study will be conducted in the Red River Delta Region, an agriculturally rich and densely populated area in northern Vietnam. Four communes (Viet Hung, Binh Minh, Tan Viet and Bach Sam) located in four different districts in the Hung Yen province will be included in the M2Q2 study, based on their general representativeness to the rural northern Vietnamese population and because the investigators have developed infrastructure to support technology-assisted behavioral interventions through community health centers (CHCs) in these communes. Each of the selected communes satisfy the following criteria: (1) have a community health center with a medical doctor; (2) are not currently participating in other studies for smoking cessation; and (3) have a minimum geographic separation of 12 kilometers (7 miles) from all other study communes to minimize possible contamination.

Recruitment and retention of study participants will be conducted by both CHC staff and community health workers. The investigators will recruit men and women, and plan for recruiting 15% women. The investigators will plan to recruit smokers regardless of their readiness to quit. Participants will not be compensated, other than being provided a cellphone if they currently do not own one.

The duration of an individual subject's participation in the study is 6 months (baseline survey, texting system, quitline data, and the 6-month follow-up survey). The duration anticipated to enroll all study subjects is 2 years, 2 months. The estimated date for the investigators to complete this study with primary analyses is the middle of year 5.

The main dependent variable is patient tobacco cessation rate (quit rate) at six months. The investigators will biochemically verify smoking status at baseline and at six months. The secondary outcome measure is self-efficacy. The investigators will administer an 12-item questionnaire (SEQ-12) to measure self-efficacy at baseline and at six months.

Study Design

Study Type:
Interventional
Actual Enrollment :
750 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Health Services Research
Official Title:
mHealth Messaging to Motivate Quitline Use and Quitting (M2Q2): RCT in Rural Vietnam
Actual Study Start Date :
Nov 23, 2018
Actual Primary Completion Date :
Apr 8, 2021
Anticipated Study Completion Date :
Mar 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Comparison

The comparison condition is designed as a minimal intervention, and allows for blinding of the patients to randomization group.

Behavioral: Comparison
Participants randomized to the comparison arm will receive twice-monthly abstinence assessments from the text messaging system, with no motivational feedback. Those in the comparison arm are neither offered nor encouraged to participate in the intervention.

Experimental: Intervention

The intervention is designed to encourage and remind smokers of the availability of the Quitline services. In addition to the one-way motivational messages, the investigators will use two-way assessments. Two-way automated texting is the ability to push out a question, have the user respond with a brief, numeric or one-word answer, and based on that answer, provide immediate feedback. The goal of these brief assessments is two-fold: 1) to assess behavior (abstinence) and motivation to use services, and 2) to return feedback tailored to each individual smoker based on the answers of the user.

Behavioral: Intervention
Participants randomized to the intervention arm will receive: Motivational Messages Abstinence and Motivation to Use Services Assessments Encouragement to access the Quitline Encouragement to use Nicotine Replacement Therapy (NRT) Provision of NRT, if requested Intervention subjects are encouraged to access the Quitline and use NRT. However, these are not mandatory components of the intervention and subjects can choose if they would like to engage with the Quitline or use NRT.
Other Names:
  • mHealth Intervention
  • Outcome Measures

    Primary Outcome Measures

    1. Participant Tobacco Cessation Rate (quit rate) at 6 months [At 6 months post-randomization]

      7 day point prevalence cessation per self-report with additional carbon monoxide monitor verification for those who report cessation.

    Secondary Outcome Measures

    1. Change in self-efficacy scores using the Self Efficacy Questionnaire (SEQ-12) [From randomization to 6 months post-randomization]

      Study team will administer the Self Efficacy Questionnaire (SEQ-12), an 12-item questionnaire to measure self-efficacy. The SEQ-12 has 6 questions under two domains, internal and external stimuli. Two composite scores are computed for each of these domains by adding the individual items. The outcome will measure the change in SEQ-12 scores from baseline to 6 months post-randomization.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. ≥18 years of age.

    2. Resident of a selected commune.

    3. Be a current smoker.

    4. Be able to receive texts and read text (literate).

    5. Not be cognitively impaired (as assessed by study staff).

    6. Not have helped develop messages used in the intervention.

    7. Not be a family member of another participant in the study.

    Exclusion Criteria:
    1. <18 years of age.

    2. Cognitively impaired (as assessed by study staff).

    3. Pregnant.

    4. Prisoner.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Institute of Population, Health, and Development (PHAD) Hanoi Vietnam

    Sponsors and Collaborators

    • University of Massachusetts, Worcester
    • Institute of Population, Health and Development, Vietnam
    • National Institutes of Health (NIH)
    • Fogarty International Center of the National Institute of Health

    Investigators

    • Principal Investigator: Rajani S Sadasivam, PhD, University of Massachusetts, Worcester

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Rajani Sadasivam, Associate Professor, Population and Quantitative Health Sciences, University of Massachusetts, Worcester
    ClinicalTrials.gov Identifier:
    NCT03567993
    Other Study ID Numbers:
    • H00012953
    • R01TW010647
    First Posted:
    Jun 26, 2018
    Last Update Posted:
    Aug 12, 2021
    Last Verified:
    Aug 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Rajani Sadasivam, Associate Professor, Population and Quantitative Health Sciences, University of Massachusetts, Worcester

    Study Results

    No Results Posted as of Aug 12, 2021